Emetine Cardiotoxicity & Cardiac Action Potential Simulator

Cellular electrophysiology and pharmacokinetics simulator of ipecac/emetine accumulation and hypokalemic arrhythmia

Clinical Scenarios:
Electrophysiology Waves: Ventricular AP & Lead II ECG ARRHYTHMIA RISK ACTIVE
Action Potential Duration (APD90) 410 ms Prolonged Plateau Phase
Calculated QTc Interval 540 ms Severe Long QT (>500 ms)
Conduction Velocity 0.28 m/s Depressed Upstroke (Phase 0)
Arrhythmia Assessment Severe / Torsades de Pointes High Risk of Sudden Arrest
Synergistic Pathophysiology of Emetine Toxicity & Anorexia Nervosa

1. Tissue Half-Life & Multi-Week Accumulation

Emetine (active alkaloid in syrup of ipecac) binds tightly to subcellular myocardial structures. Because elimination half-life exceeds 14 days, chronic ingestion causes cumulative toxicity despite small intermittent doses.

2. Double Ion Channel Inhibition (I_Kr & I_Na)

Emetine blocks the hERG/I_Kr potassium channel (delaying repolarization) and voltage-gated sodium channels (Phase 0 slope reduction). Conduction velocity drops while APD widens dramatically.

3. Hypokalemic Amplification

Severe hypokalemia (< 3.0 mM) from purging/starvation further impairs I_Kr gating. The combined effect creates pronounced Early Afterdepolarizations (EADs) and lethal Torsades de Pointes polymorphic ventricular tachycardia.

Enjoy this tool? Build your own with Super